• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化合并轻中度限制的平均肺动脉压进展。

Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction.

机构信息

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.

Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.

出版信息

Respirology. 2017 Jul;22(5):986-990. doi: 10.1111/resp.12986. Epub 2017 Jan 24.

DOI:10.1111/resp.12986
PMID:28117530
Abstract

BACKGROUND AND OBJECTIVE

Elevation of mean pulmonary arterial pressure (MPAP) is associated with poor prognosis in patients with idiopathic pulmonary fibrosis (IPF), yet the progression of MPAP in patients with IPF has not been sufficiently elucidated. We evaluated serial changes in MPAP and its determinants in patients with IPF with mild to moderate restriction.

METHODS

We retrospectively reviewed patients with IPF who underwent initial evaluations including right heart catheterization (RHC) in our institute from May 2007 to December 2013 with follow-up RHC at least 1 year later. Patients with forced vital capacity (FVC) < 50% predicted or those with pulmonary artery wedge pressure >15 mm Hg were excluded.

RESULTS

A total of 95 patients were included. Median follow-up time of second RHC was 1.8 years. MPAP increased significantly at follow-up (from 16.8 to 20.2 mm Hg; P < 0.001), and annual change in MPAP (ΔMPAP) was 1.8 mm Hg/year. In multiple regression analysis, the lowest oxygen saturation (SpO ) at 6-min walk test (6MWT) was an independent predictor of ΔMPAP. When adjusted for age, sex, baseline MPAP and FVC % predicted, ΔMPAP was a significant predictor of mortality (hazard ratio: 1.21; P = 0.001).

CONCLUSION

ΔMPAP was significantly associated with desaturation in the 6MWT, and with increased mortality in patients with IPF with mild to moderate restriction.

摘要

背景和目的

平均肺动脉压(MPAP)升高与特发性肺纤维化(IPF)患者预后不良相关,但 IPF 患者 MPAP 的进展尚未得到充分阐明。我们评估了伴有轻度至中度限制的 IPF 患者 MPAP 及其决定因素的连续变化。

方法

我们回顾性分析了 2007 年 5 月至 2013 年 12 月在我院接受初始评估(包括右心导管检查[RHC])并在至少 1 年后进行后续 RHC 的 IPF 患者。排除了用力肺活量(FVC)<50%预计值或肺动脉楔压>15mmHg 的患者。

结果

共纳入 95 例患者。第二次 RHC 的中位随访时间为 1.8 年。MPAP 在随访时显著升高(从 16.8 至 20.2mmHg;P<0.001),MPAP 的年变化量(ΔMPAP)为 1.8mmHg/年。多元回归分析显示,6 分钟步行试验(6MWT)时的最低血氧饱和度(SpO )是ΔMPAP 的独立预测因子。在校正年龄、性别、基线 MPAP 和 FVC%预计值后,ΔMPAP 是死亡率的显著预测因子(危险比:1.21;P=0.001)。

结论

ΔMPAP 与 6MWT 中的低氧血症显著相关,与伴有轻度至中度限制的 IPF 患者的死亡率增加相关。

相似文献

1
Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction.特发性肺纤维化合并轻中度限制的平均肺动脉压进展。
Respirology. 2017 Jul;22(5):986-990. doi: 10.1111/resp.12986. Epub 2017 Jan 24.
2
Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.特发性肺纤维化初始评估中肺动脉高压作为预后指标。
Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.
3
Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.超声心动图、6 分钟步行距离和距离饱和度乘积预测特发性肺纤维化中的肺动脉高压。
Respir Care. 2010 May;55(5):584-8.
4
CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.CT 测定的肺动脉与主动脉比值可预测特发性肺纤维化患者肺动脉高压和生存情况。
Respirology. 2017 Oct;22(7):1393-1399. doi: 10.1111/resp.13066. Epub 2017 May 10.
5
Pulmonary hypertension in chronic lung diseases.慢性肺部疾病相关肺动脉高压。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036.
6
Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.肺动脉压作为以肺部为主的结缔组织病预后指标的意义。
PLoS One. 2014 Sep 30;9(9):e108339. doi: 10.1371/journal.pone.0108339. eCollection 2014.
7
Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis.特发性肺纤维化患者 6 分钟步行试验与肺血流动力学的相关性研究。
Respir Med. 2012 Nov;106(11):1613-21. doi: 10.1016/j.rmed.2012.07.013. Epub 2012 Aug 16.
8
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.晚期特发性肺纤维化患者肺动脉高压的患病率及预后
Chest. 2006 Mar;129(3):746-52. doi: 10.1378/chest.129.3.746.
9
A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis.特发性肺纤维化中平均肺动脉压升高的预测评分系统。
Eur Respir J. 2018 Jan 18;51(1). doi: 10.1183/13993003.01311-2017. Print 2018 Jan.
10
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.特发性肺纤维化合并轻度生理损害的疾病进展:来自澳大利亚特发性肺纤维化登记处的分析。
BMC Pulm Med. 2018 Jan 25;18(1):19. doi: 10.1186/s12890-018-0575-y.

引用本文的文献

1
A Twist in the Fibrotic Tale: The Overlooked Vasculopathy in Idiopathic Pulmonary Fibrosis.纤维化故事中的一个转折:特发性肺纤维化中被忽视的血管病变
Am J Respir Crit Care Med. 2025 Jun;211(6):897-898. doi: 10.1164/rccm.202502-0465ED.
2
Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant.等待肺移植的特发性肺纤维化患者的系列肺血流动力学研究
Am J Respir Crit Care Med. 2025 Jun;211(6):984-991. doi: 10.1164/rccm.202411-2157OC.
3
Right Heart Catheterization Accurately Diagnoses Pulmonary Hypertension in Patients With Interstitial Lung Disease: Results From a Long-Term Cohort Study.
右心导管检查可准确诊断间质性肺疾病患者的肺动脉高压:一项长期队列研究的结果
Pulm Circ. 2025 Jan 26;15(1):e70035. doi: 10.1002/pul2.70035. eCollection 2025 Jan.
4
Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients.揭开沉默的威胁:改善特发性肺纤维化患者肺动脉高压的筛查方法。
Medicina (Kaunas). 2023 Dec 28;60(1):58. doi: 10.3390/medicina60010058.
5
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.PH-ILD 中的 INCREASE 研究的生存分析:评估治疗交叉对总死亡率的影响。
Thorax. 2024 Mar 15;79(4):301-306. doi: 10.1136/thorax-2023-220821.
6
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension.与间质性肺疾病相关的肺动脉高压的发病机制、临床特征及表型:肺血管研究所创新药物开发计划 - 3组肺动脉高压共识声明
Pulm Circ. 2023 Apr 1;13(2):e12213. doi: 10.1002/pul2.12213. eCollection 2023 Apr.
7
Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection.间质性肺疾病患者的肺动脉高压:一种早期检测工具。
Pulm Circ. 2022 Oct 1;12(4):e12141. doi: 10.1002/pul2.12141. eCollection 2022 Oct.
8
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.COPD 相关肺动脉高压的新兴表型:实用指南。
Curr Opin Pulm Med. 2022 Sep 1;28(5):343-351. doi: 10.1097/MCP.0000000000000890. Epub 2022 Jul 16.
9
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.特发性肺动脉高压对慢性肺部疾病患者生存的影响。
Respiration. 2022;101(8):717-727. doi: 10.1159/000524263. Epub 2022 Apr 22.
10
Pulmonary hypertension in chronic lung disease and hypoxia.慢性肺部疾病与低氧血症相关性肺动脉高压
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01914-2018. Print 2019 Jan.